My watch list
my.bionity.com  
Login  
NEWS
Current news

Evotec and Takeda enter into multi-year gene therapy research alliance

07-Apr-2020 Evotec SE announced that Evotec GT, with operations in Austria, has established a long-term research alliance with Takeda to support Takeda’s growing number of research stage gene therapy discovery programmes. Under the alliance, Evotec will support multiple Takeda programmes targeting cond ... more

Making the invisible visible

Highly detailed insights into tissue samples

07-Apr-2020 Entangled photons can be used to improve imaging and measurement techniques. A team of researchers from the Fraunhofer Institute for Applied Optics and Precision Engineering IOF in Jena has developed a quantum imaging solution that can facilitate highly detailed insights into tissue samples ... more

First SARS-CoV-2 genomes in Austria openly available

07-Apr-2020 The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM in close collaboration with the Medical University of Vienna. The project aims at sequencing 1,000 viral genomes obt ... more

Fighting SARS-CoV-2 in human blood vessel organoids

06-Apr-2020 SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – a team of international scientists produced groundbreaki ... more

Remote medical image diagnosis

Startup provides app free of charge during corona crisis

06-Apr-2020 The current crises caused by the fast spread of covid-19 is forcing clinics and its medical staff to take actions that otherwise would require months or years: Home office and the provision of mobile software solutions. mbits, a spin-off of the German Cancer Research Center (DKFZ), has impl ... more

Turning cells into computers with protein logic gates

Biochemists have created "smart" proteins that function inside human cells by turning genes on and off

06-Apr-2020 The same basic tools that allow computers to function are now being used to control life at the molecular level. The advances have implications for future medicines and synthetic biology. Reporting April 2 in the journal Science, a team led by the University of Washington School of Medicine ... more

Corona research at BESSY II: Two days of measuring operation to find the right key

03-Apr-2020 The Berlin Synchrotron Source BESSY II of the Helmholtz-Zentrum Berlin (HZB) will resume operation for two days. Scientists intend to use the intense X-ray radiation from BESSY II to search for active substances against the corona virus SARS-CoV2. Almost two hundred samples from an importan ... more

Neurimmune and Ethris plan to develop inhaled mRNA-based antibody therapy for the treatment of Covid-19

Companies expect to initiate clinical testing in 2020

03-Apr-2020 Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of Covid-19. The collaboration brings together Neurimmune’s expertise in developing human antibodies based on high-t ... more

Researchers Discover New Crystalline Calcium Phosphate

The mineral could be used in implantology, drug development or water treatment

03-Apr-2020 A new type of crystalline calcium phosphate has been discovered and analysed in the laboratories of Leibniz University Hannover (LUH). Calcium orthophosphates, a group of biominerals, are a vital part of the human body and can be found in solid structures such as bones or teeth. Calcium ort ... more

New blood test detects wide range of cancers

Test proved able to detect and indicate site of dozens of types of cancer with high accuracy

03-Apr-2020 In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute and the Mayo Clinic. The res ... more

All news

First SARS-CoV-2 genomes in Austria openly available

07-Apr-2020 The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM in close collaboration with the Medical University of Vienna. The project aims at sequencing 1,000 viral genomes obt ... more

Corona research at BESSY II: Two days of measuring operation to find the right key

03-Apr-2020 The Berlin Synchrotron Source BESSY II of the Helmholtz-Zentrum Berlin (HZB) will resume operation for two days. Scientists intend to use the intense X-ray radiation from BESSY II to search for active substances against the corona virus SARS-CoV2. Almost two hundred samples from an importan ... more

A molecular map for the plant sciences

First comprehensive map of the proteome of the model plant Arabidopsis thaliana

16-Mar-2020 Plants are essential for life on earth. They provide food for essentially all organisms, oxygen for breathing, and they regulate the climate of the planet. Proteins play a key role in controlling all aspects of life including plants. Under the leadership of the Technical University of Munic ... more

Virtual screening for active substances against the coronavirus

11-Mar-2020 The University of Basel is part of the global search for a drug to fight the rampant coronavirus. Researchers in the Computational Pharmacy group have so far virtually tested almost 700 million substances, targeting a specific site on the virus – with the aim of inhibiting its multiplicatio ... more

Thermo Fisher Scientific to Acquire QIAGEN

03-Mar-2020 Thermo Fisher Scientific Inc. and QIAGEN N.V. announced that their boards of directors, as well as the managing board of QIAGEN N.V., have unanimously approved Thermo Fisher’s proposal to acquire QIAGEN for €39 per share in cash. The offer price represents a premium of approximately 23% to ... more

Tonsils as a testbed

02-Mar-2020 Biomedical researchers at LMU have isolated immune cells from human tonsils obtained following routine surgery, and used them to analyze aspects of the immune response and test the effects of anti-inflammatory agents at the cellular level. Human tissues that have been surgically removed fro ... more

analytica 2020: Bioanalysis for personalized medicine

28-Feb-2020 The world’s leading trade fair analytica provides more comprehensive information about the rapid progress in bioanalysis and biotechnology than any other event does. Know-how for the daily work in the biological lab is to be had in the Forum Biotech in Hall A3. This is also where the Financ ... more

Bohui Innovation Biotechnology will acquire the Interchim group

27-Feb-2020 Advion Inc. announces parent company Beijing Bohui Innovation Biotechnology Co., Ltd., has filed its intention to acquire Adchim SAS, the parent company of the Interchim group companies. This transaction will subsequently result in the combination of Bohui’s subsidiary Advion Inc., a leader ... more

On the trail of cancer stem cells

What goes on inside and between individual cells during the very earliest stages of tumor development?

24-Feb-2020 Single cell sequencing technologies and a mouse model have enabled researchers to comprehensively map the cellular diversity of whole salivary gland tumors and trace the path of cancer stem cells. Two research teams from the Max Delbrück Center for Molecular Medicine and their collaborators ... more

Observing proteins in their natural environment

11-Feb-2020 Proteins can be responsible for the fact that the active ingredients of drugs are simply released from the target cells. You can watch them do this now. Certain medications, such as those used to treat cancer, lose their effect because proteins in the membrane of the target cell simply expe ... more

All news on bioanalytics

Turning cells into computers with protein logic gates

Biochemists have created "smart" proteins that function inside human cells by turning genes on and off

06-Apr-2020 The same basic tools that allow computers to function are now being used to control life at the molecular level. The advances have implications for future medicines and synthetic biology. Reporting April 2 in the journal Science, a team led by the University of Washington School of Medicine ... more

A genetic nano-toolkit for the generation of new biomaterials

26-Mar-2020 Magnetic bacteria might soon be used for the production of novel biomaterials. A team of microbiologists at the University of Bayreuth led by Prof. Dr. Dirk Schüler developed a modular system for the genetic reprogramming of bacteria, thereby turning the organisms into cell factories for mu ... more

QIAGEN names Thierry Bernard as Chief Executive Officer

25-Mar-2020 QIAGEN announced that Thierry Bernard has been named Chief Executive Officer. Additionally, a Joint Meeting of the Supervisory Board and the Managing Board has resolved to propose Mr. Bernard, who has been with QIAGEN since 2015, for election as Chief Executive Officer and a Managing Direct ... more

European and U.S. antitrust authorities clear acquisition of select Danaher Life Science businesses by Sartorius

23-Mar-2020 On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction originally announced in October 2019, the comp ... more

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

20-Mar-2020 Pfizer Inc. and BioNTech SE announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The companies have executed a Material Transfer an ... more

New more powerful genome editing method

Scientists can now edit multiple genome fragments at a time

20-Mar-2020 Toronto scientists can now edit multiple sites in the genome at the same time to learn how different DNA stretches co-operate in health and disease. CRISPR-based DNA editing has revolutionized the study of the human genome by allowing precise deletion of any human gene to glean insights int ... more

Sustainable production of an industrially relevant amino acid by fermentation

Scientist uses Synthetic Biology for the environmentally friendly production of D-phenylglycine

19-Mar-2020 A team led by Professor Yvonne Mast from the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH in Braunschweig has succeeded in establishing a fermentative pathway for the production of D-phenylglycine - an important building block for products of the pharmac ... more

Evonik achieves major biotech breakthrough with a new animal-free and fermentation-based collagen platform

Recombinant collagen mimics attributes of human collagen

19-Mar-2020 Evonik announced the development of an advanced collagen platform that is made via fermentation-based processes and devoid of animal- or human-derived materials. The recombinant technology will, for the first time, provide pharmaceutical, medical, cell culture and tissue engineering markets ... more

New kind of CRISPR technology to target RNA, including RNA viruses like coronavirus

18-Mar-2020 CRISPR-based genetic screens have helped scientists identify genes that are key players in sickle-cell anemia, cancer immunotherapy, lung cancer metastasis, and many other diseases. However, these genetic screens are limited in scope: They can only edit or target DNA. For many regions of th ... more

CureVac rejects current rumors of an acquisition

Company focuses on the development of mRNA-based coronavirus vaccine to protect people worldwide

16-Mar-2020 CureVac AG confirmed that internal efforts are focused on the development of a coronavirus vaccine with the goal to reach, help and to protect people and patients worldwide. As a consequence, the company is in contact with especially CEPI and many other organizations and authorities worldwi ... more

All news on biotechnology

Remote medical image diagnosis

Startup provides app free of charge during corona crisis

06-Apr-2020 The current crises caused by the fast spread of covid-19 is forcing clinics and its medical staff to take actions that otherwise would require months or years: Home office and the provision of mobile software solutions. mbits, a spin-off of the German Cancer Research Center (DKFZ), has impl ... more

New blood test detects wide range of cancers

Test proved able to detect and indicate site of dozens of types of cancer with high accuracy

03-Apr-2020 In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute and the Mayo Clinic. The res ... more

University of Innsbruck develops novel corona test method

02-Apr-2020 Michael Traugott and the spin-off company Sinsoma GmbH, together with the Departments of Zoology and Microbiology at the University of Innsbruck, are developing a new PCR system for the detection of the SARS-CoV-2 virus. This new PCR method works with different analytical materials that are ... more

Pool testing of SARS-CoV-02 samples increases worldwide test capacities many times over

01-Apr-2020 Researchers at the German Red Cross Blood Donor Service in Frankfurt headed by Professor Erhard Seifried, and the Institute for Medical Virology at the University Hospital Frankfurt at Goethe University headed by Professor Sandra Ciesek succeeded in developing a procedure that makes it poss ... more

2020 Eppendorf Award for Young European Investigators Goes to Randall Platt

Prize Ceremony Postponed to 2021 in Response to COVID-19 Outbreak

01-Apr-2020 In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 25th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, ... more

Bosch develops rapid test for COVID-19

Test results enable differential diagnosis in under 2.5 hours

31-Mar-2020 The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help ... more

Staining Cycles with Black Holes

Ultrafast repeated staining and destaining of cell samples for tumor diagnostics

27-Mar-2020 In the treatment of tumors, microenvironment plays an important role. It often contains immune cells that are so changed that they promote tumor growth. In the journal Angewandte Chemie, scientists have introduced a method by which cell samples from tumors and their surroundings can rapidly ... more

FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

25-Mar-2020 PerkinElmer, Inc. announced that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ... more

QIAGEN names Thierry Bernard as Chief Executive Officer

25-Mar-2020 QIAGEN announced that Thierry Bernard has been named Chief Executive Officer. Additionally, a Joint Meeting of the Supervisory Board and the Managing Board has resolved to propose Mr. Bernard, who has been with QIAGEN since 2015, for election as Chief Executive Officer and a Managing Direct ... more

New device quickly detects harmful bacteria in blood

Tiny device could help professionals diagnose and fight deadly infections

25-Mar-2020 Engineers have created a tiny device that can rapidly detect harmful bacteria in blood, allowing health care professionals to pinpoint the cause of potentially deadly infections and fight them with drugs. "The rapid identification of drug-resistant bacteria allows health care providers to p ... more

All news on diagnostics

Eppendorf acquires centrifuge business of Koki Holdings Co., Ltd.

20-Mar-2020 Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG ... more

analytica 2020 is postponed

New date in the fall of 2020

09-Mar-2020 Due to the increasing spread of the coronavirus (COVID-19) in Europe and on the basis of the recommendations of the Bavarian State Government as well as of the responsible health authorities, Messe München feels compelled to postpone analytica 2020. This measure is taken in consultation wit ... more

Wolfgang Kintzel to Become Cellbox Solutions’ CEO

26-Feb-2020 Cellbox Solutions announces the expansion of its Board of Directors and the appointment of a new CEO - Wolfgang Kintzel will start as Chief Executive Officer effective March 1, 2020. The founder Prof. Kathrin Adlkofer will support the board in the function as COO. Wolfgang Kintzel has an ex ... more

Simplifying Progress: Sartorius sharpens its brand focus

25-Feb-2020 New brand promise, new logo, new colors – Sartorius looks different now. The company has revised its brand look. At the focus of this relaunch is Sartorius’ new brand promise that it summarizes in its new claim: Simplifying Progress. With its products and technologies, the company aims to s ... more

Sartorius looks optimistically to 2020

19-Feb-2020 Sartorius confirmed its preliminary figures upon publication of its 2019 Annual Report. Group sales revenue rose in constant currencies by 14.8% (reported: +16.7%) to 1,827.0 million euros. Growth was almost entirely organic as the acquisition of the cell culture media specialist Biological ... more

The digital laboratory live and tangible

12-Feb-2020 Visitors to analytica 2020 can experience the laboratory of the future in a special show that is unique in the whole world: 18 partners from science and industry have joined forces to demonstrate device networking, collaborative robotics and user interaction, using the example of eight work ... more

Sartorius is set to grow further

Sartorius achieves significant increases in sales revenue and earnings again in 2019

29-Jan-2020 Sartorius has continued on its profitable growth track in fiscal 2019. The Group grew by double digits in sales revenue, order intake and earnings, recording gains in both divisions and across all regions. According to preliminary figures, Group sales revenue rose in constant currencies by ... more

Waters to Acquire Andrew Alliance

15-Jan-2020 Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more

Eppendorf with new CEO dual leadership

Former CEO, Thomas Bachmann, left the company

10-Dec-2019 The Supervisory Board of Eppendorf AG has appointed Eva von Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Business Area Sample Handling, as Co-Chief Executive Officers of Eppendorf AG. Both will succeed Thomas Bachmann, the former President & CEO of ... more

CEM acquires key assets of Intavis Bioanalytical Instruments

31-Oct-2019 CEM Corporation announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, i ... more

All news on laborausstattung / laborbedarf

Evotec and Takeda enter into multi-year gene therapy research alliance

07-Apr-2020 Evotec SE announced that Evotec GT, with operations in Austria, has established a long-term research alliance with Takeda to support Takeda’s growing number of research stage gene therapy discovery programmes. Under the alliance, Evotec will support multiple Takeda programmes targeting cond ... more

Neurimmune and Ethris plan to develop inhaled mRNA-based antibody therapy for the treatment of Covid-19

Companies expect to initiate clinical testing in 2020

03-Apr-2020 Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of Covid-19. The collaboration brings together Neurimmune’s expertise in developing human antibodies based on high-t ... more

Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

24-Mar-2020 Roche announced that it are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Servi ... more

Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

20-Mar-2020 Pfizer Inc. and BioNTech SE announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The companies have executed a Material Transfer an ... more

CureVac rejects current rumors of an acquisition

Company focuses on the development of mRNA-based coronavirus vaccine to protect people worldwide

16-Mar-2020 CureVac AG confirmed that internal efforts are focused on the development of a coronavirus vaccine with the goal to reach, help and to protect people and patients worldwide. As a consequence, the company is in contact with especially CEPI and many other organizations and authorities worldwi ... more

Bristol pioneers use of VR for designing new drugs

16-Mar-2020 Researchers at the University of Bristol are pioneering the use of virtual reality (VR) as a tool to design the next generation of drug treatments. The findings, published in the journal PLOS ONE describe how researchers used VR to understand how common medications work on a molecular level ... more

Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG

12-Mar-2020 CureVac AG announced that company founder and Chairman of the Supervisory Board Ingmar Hoerr is replacing Daniel Menichella in his function as Chief Executive Officer (CEO). "On behalf of the Supervisory Board I would like to thank Dan Menichella very much for the great contributions he has ... more

Sugar as a remedy for the common cold

Start-up developing therapies to combat viral infections

11-Mar-2020 Viral infections are currently more topical than ever. Not only are coronavirus and influenza constantly in the news but it is also the season for colds – and, as we all know, colds are caused by rhinovirus. A Medical University of Vienna start-up, "G.ST Antivirals GmbH" now has viral infec ... more

Merck Meets all Financial Targets and Makes Significant Strategic Progress

06-Mar-2020 Merck met all its financial targets and thus grew profitably in fiscal 2019. At the same time, Merck also made significant progress in executing its strategic agenda. “We delivered on our promise and achieved growth for all our key performance indicators, namely net sales, EBITDA pre and EP ... more

New medicines against severe inflammatory diseases

Start-up Quench Bio closes USD 50M Series A financing

28-Feb-2020 The Lead Discovery Center GmbH (LDC), the Max Planck Society (MPG) and Max Planck Innovation (MI) announce that their associated company Quench Bio Inc., Cambridge, USA has raised USD 50 million in a Series A financing round. The financing was led by RA Capital Management (RA Capital) and i ... more

All news on pharma

First SARS-CoV-2 genomes in Austria openly available

07-Apr-2020 The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM in close collaboration with the Medical University of Vienna. The project aims at sequencing 1,000 viral genomes obt ... more

Fighting SARS-CoV-2 in human blood vessel organoids

06-Apr-2020 SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – a team of international scientists produced groundbreaki ... more

Remote medical image diagnosis

Startup provides app free of charge during corona crisis

06-Apr-2020 The current crises caused by the fast spread of covid-19 is forcing clinics and its medical staff to take actions that otherwise would require months or years: Home office and the provision of mobile software solutions. mbits, a spin-off of the German Cancer Research Center (DKFZ), has impl ... more

Corona research at BESSY II: Two days of measuring operation to find the right key

03-Apr-2020 The Berlin Synchrotron Source BESSY II of the Helmholtz-Zentrum Berlin (HZB) will resume operation for two days. Scientists intend to use the intense X-ray radiation from BESSY II to search for active substances against the corona virus SARS-CoV2. Almost two hundred samples from an importan ... more

Researchers Discover New Crystalline Calcium Phosphate

The mineral could be used in implantology, drug development or water treatment

03-Apr-2020 A new type of crystalline calcium phosphate has been discovered and analysed in the laboratories of Leibniz University Hannover (LUH). Calcium orthophosphates, a group of biominerals, are a vital part of the human body and can be found in solid structures such as bones or teeth. Calcium ort ... more

Blocking the Iron Transport Could Stop Tuberculosis

02-Apr-2020 The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply. When the iron transport into the bacteria is inhibited, the pathogen can no longer grow. ... more

Scientists discover novel role for self-recycling process in the brain

Proteins classically associated with autophagy regulate the speed of intracellular transport

01-Apr-2020 Scientists from the laboratory of Dr. Natalia Kononenko at the CECAD Center of Excellence in Aging Research at the University of Cologne have found out that autophagy – the process of cellular self-recycling, or waste clearance – is dispensable for the survival of the neurons in mice. The n ... more

Missing link in coronavirus jump from bats to humans could be pangolins, not snakes

31-Mar-2020 As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus' genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares "uncanny similarities" with an HIV-1 prote ... more

Phage capsid against influenza

Perfectly fitting inhibitor prevents viral infection

31-Mar-2020 A new approach brings the hope of new therapeutic options for suppressing seasonal influenza and avian flu: On the basis of an empty – and therefore non-infectious – shell of a phage virus, researchers from Berlin have developed a chemically modified phage capsid that “stifles” influenza vi ... more

Microflora of glasses: the mini universe on your nose

31-Mar-2020 Almost every second European wears glasses. Due to their central position on our face, close to our mouth and nose, and to their regular contact with skin, particularly our hands, glasses have been proven to be frequently contaminated with microorganisms. Furtwangen University has now publi ... more

All news on healthcare
News by department
  • Products

    Remote medical image diagnosis

    Startup provides app free of charge during corona crisis

    06-Apr-2020 The current crises caused by the fast spread of covid-19 is forcing clinics and its medical staff to take actions that otherwise would require months or years: Home office and the provision of mobile software solutions. mbits, a spin-off of the German Cancer Research Center (DKFZ), has impl ... more

    Neurimmune and Ethris plan to develop inhaled mRNA-based antibody therapy for the treatment of Covid-19

    Companies expect to initiate clinical testing in 2020

    03-Apr-2020 Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of Covid-19. The collaboration brings together Neurimmune’s expertise in developing human antibodies based on high-t ... more

    Bosch develops rapid test for COVID-19

    Test results enable differential diagnosis in under 2.5 hours

    31-Mar-2020 The coronavirus SARS-CoV-2 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help ... more

  • Business

    European and U.S. antitrust authorities clear acquisition of select Danaher Life Science businesses by Sartorius

    23-Mar-2020 On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction originally announced in October 2019, the comp ... more

    Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus

    Company scaling up production at its U.S. manufacturing location

    20-Mar-2020 Abbott announced that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company's molecular test for novel coronavirus (COVID-19). Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA tests to existing customers in the U.S. The tests ... more

    Eppendorf acquires centrifuge business of Koki Holdings Co., Ltd.

    20-Mar-2020 Eppendorf AG and Koki Holdings Co., Ltd., have reached an agreement that Eppendorf will acquire Koki’s centrifuge business, including the premium himac brand. A corresponding agreement was signed by both companies in Tokyo. The acquisition marks a targeted step by Hamburg-based Eppendorf AG ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Making the invisible visible

    Highly detailed insights into tissue samples

    07-Apr-2020 Entangled photons can be used to improve imaging and measurement techniques. A team of researchers from the Fraunhofer Institute for Applied Optics and Precision Engineering IOF in Jena has developed a quantum imaging solution that can facilitate highly detailed insights into tissue samples ... more

    First SARS-CoV-2 genomes in Austria openly available

    07-Apr-2020 The first 21 SARS-CoV-2 genomes in Austria have now been completed and published within the scope of the “Mutational Dynamics of SARS-CoV-2” project recently launched by CeMM in close collaboration with the Medical University of Vienna. The project aims at sequencing 1,000 viral genomes obt ... more

    Fighting SARS-CoV-2 in human blood vessel organoids

    06-Apr-2020 SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – a team of international scientists produced groundbreaki ... more

  • People

    2020 Eppendorf Award for Young European Investigators Goes to Randall Platt

    Prize Ceremony Postponed to 2021 in Response to COVID-19 Outbreak

    01-Apr-2020 In 2020, Eppendorf AG, the Hamburg life science company is presenting its highly prestigious research prize for the 25th time. The independent Eppendorf Award Jury chaired by Prof. Reinhard Jahn selected Prof. Dr. Randall J. Platt, Assistant Professor of Biological Engineering, ETH Zurich, ... more

    QIAGEN names Thierry Bernard as Chief Executive Officer

    25-Mar-2020 QIAGEN announced that Thierry Bernard has been named Chief Executive Officer. Additionally, a Joint Meeting of the Supervisory Board and the Managing Board has resolved to propose Mr. Bernard, who has been with QIAGEN since 2015, for election as Chief Executive Officer and a Managing Direct ... more

    Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG

    12-Mar-2020 CureVac AG announced that company founder and Chairman of the Supervisory Board Ingmar Hoerr is replacing Daniel Menichella in his function as Chief Executive Officer (CEO). "On behalf of the Supervisory Board I would like to thank Dan Menichella very much for the great contributions he has ... more

  • Finances

    Merck Meets all Financial Targets and Makes Significant Strategic Progress

    06-Mar-2020 Merck met all its financial targets and thus grew profitably in fiscal 2019. At the same time, Merck also made significant progress in executing its strategic agenda. “We delivered on our promise and achieved growth for all our key performance indicators, namely net sales, EBITDA pre and EP ... more

    New medicines against severe inflammatory diseases

    Start-up Quench Bio closes USD 50M Series A financing

    28-Feb-2020 The Lead Discovery Center GmbH (LDC), the Max Planck Society (MPG) and Max Planck Innovation (MI) announce that their associated company Quench Bio Inc., Cambridge, USA has raised USD 50 million in a Series A financing round. The financing was led by RA Capital Management (RA Capital) and i ... more

    Bayer strategically and operationally successful

    27-Feb-2020 Bayer was strategically and operationally successful last year. “We delivered in 2019 and kept our promises in all areas,” Werner Baumann, Chairman of the Board of Management, said on Thursday at the Financial News Conference in Leverkusen. “We achieved our financial targets despite coming ... more

  • Cooperation

    Evotec and Takeda enter into multi-year gene therapy research alliance

    07-Apr-2020 Evotec SE announced that Evotec GT, with operations in Austria, has established a long-term research alliance with Takeda to support Takeda’s growing number of research stage gene therapy discovery programmes. Under the alliance, Evotec will support multiple Takeda programmes targeting cond ... more

    Neurimmune and Ethris plan to develop inhaled mRNA-based antibody therapy for the treatment of Covid-19

    Companies expect to initiate clinical testing in 2020

    03-Apr-2020 Neurimmune AG and Ethris GmbH announced an exclusive partnership to develop mRNA-encoded, neutralizing anti-SARS-CoV-2 antibodies administered by inhalation for the treatment of Covid-19. The collaboration brings together Neurimmune’s expertise in developing human antibodies based on high-t ... more

    Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine

    20-Mar-2020 Pfizer Inc. and BioNTech SE announced that the companies have agreed to a letter of intent regarding the co-development and distribution (excluding China) of a potential mRNA-based coronavirus vaccine aimed at preventing COVID-19 infection. The companies have executed a Material Transfer an ... more

  • Technology

    Domain Therapeutics is granted European and US patent for biosensors assessing GPCR trafficking

    05-Feb-2020 Domain Therapeutics announced that it has been granted a patent in the US and in Europe covering a novel family of biosensors.   The patent, entitled ‘Biosensors for monitoring biomolecule localization and trafficking in cells’, was initially filed by Prof. Michel Bouvier and his team and i ... more

    Printing nanoparticle shapes for medical applications

    18-Apr-2019 Personal drug delivery or nano-robotic systems could be a key concept for future medical applications. In this context, scientists around David Ng (Department of Prof. Tanja Weil) of the Max Planck Institute for Polymer Research (MPI-P) have recently developed a technology to customize the ... more

    BioMCN to produce renewable methanol with green hydrogen

    27-Feb-2019 Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry. Nouryon and Gasunie are currently inves ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

    Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management

    22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more

    Merck announces the winners of its Advance Biotech Grant program

    Merck Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain

    31-May-2019 Merck announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center (Massachusetts, U.S.). The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their thera ... more

  • Politics

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

    15 emerging technologies that could reduce global catastrophic biological risks

    11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more

  • Manufacturing

    Beiersdorf provides 500 tons of disinfectant in Europe

    20-Mar-2020 Beiersdorf ramps up productions of medical grade disinfectants within its European production network to support the society’s collective fight against the coronavirus pandemic. In a first step, Beiersdorf AG will provide 500 tons of the urgently needed disinfectants to critical public emer ... more

    QIAGEN dramatically ramping up global production capacity for RNA extraction kits for use in detection of SARS-CoV-2 coronavirus

    18-Mar-2020 QIAGEN announced plans to dramatically ramp up global production capacity of RNA extraction kits that are used as part of workflows around the world to detect nucleic acid from SARS-CoV-2, the novel coronavirus that causes COVID-19. QIAGEN has historically allocated global production capaci ... more

    3D printing of tablets

    Merck and AMCM cooperate

    28-Feb-2020 Merck and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets. AMCM offers customized additive manufacturing solutions. The cooperation targets GMP-conform (Good Manufacturing Practice) tablet formulation development and production for clinical trials i ... more

  • Career

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

    KNAUER among the top one percent of employers in Germany

    28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE